Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose

Jessica R Allegretti^{1

2}, Monika Fischer³, Sashidhar V Sagi³, Matthew E Bohm³, Hala M Fadda⁴, Sejal R Ranmal⁵, Shrish Budree^{6

7}, Abdul W Basit^{5

8}, Dean L Glettig⁹, Eva L de la Serna⁹, Amanda Gentile⁹, Ylaine Gerardin⁹, Sonia Timberlake⁹, Rotem Sadovsky⁹, Mark Smith⁹, Zain Kassam⁹

Affiliations

¹ Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA. jallegretti@partners.org.
² Harvard Medical School, Boston, MA, USA. jallegretti@partners.org.
³ Division of Gastroenterology, Indiana University, Indianapolis, IN, USA.
⁴ College of Pharmacy and Health Sciences, Butler University, Indianapolis, IN, USA.
⁵ Intract Pharma, London, UK.
⁶ OpenBiome, Somerville, MA, USA.
⁷ University of Cape Town, Cape Town, South Africa.
⁸ School of Pharmacy, University College London, London, UK.
⁹ Finch Therapeutics, Somerville, MA, USA.

PMID: 30778870
DOI: 10.1007/s10620-019-05527-4

Published Erratum

Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose

Jessica R Allegretti et al. Dig Dis Sci. 2019 Jul.

. 2019 Jul;64(7):2059.

doi: 10.1007/s10620-019-05527-4.

Authors

Affiliations

¹ Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA. jallegretti@partners.org.
² Harvard Medical School, Boston, MA, USA. jallegretti@partners.org.
³ Division of Gastroenterology, Indiana University, Indianapolis, IN, USA.
⁴ College of Pharmacy and Health Sciences, Butler University, Indianapolis, IN, USA.
⁵ Intract Pharma, London, UK.
⁶ OpenBiome, Somerville, MA, USA.
⁷ University of Cape Town, Cape Town, South Africa.
⁸ School of Pharmacy, University College London, London, UK.
⁹ Finch Therapeutics, Somerville, MA, USA.

PMID: 30778870
DOI: 10.1007/s10620-019-05527-4

Abstract

The original version of the article unfortunately contained an error in article title. The corrected title is 'Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose'.

PubMed Disclaimer

Erratum for

Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Lose Dose.
Allegretti JR, Fischer M, Sagi SV, Bohm ME, Fadda HM, Ranmal SR, Budree S, Basit AW, Glettig DL, de la Serna EL, Gentile A, Gerardin Y, Timberlake S, Sadovsky R, Smith M, Kassam Z. Allegretti JR, et al. Dig Dis Sci. 2019 Jun;64(6):1672-1678. doi: 10.1007/s10620-018-5396-6. Epub 2018 Dec 5. Dig Dis Sci. 2019. PMID: 30519847

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose

Affiliations

Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources